2025 CMG Lunch and Learn EVAL|Timely Media Topics Related to Autism

First Name *

Last Name *

Email *

Please fill in your Ethos Login Email

1

In what aspect(s) do you feel satisfied with this session? (Check all that apply)

The session met my learning needs.

The content was relevant to my current practices.

The conversation was interprofessional.

The conversation was constructive.

None

Please check here and explain your choice:____________

1 Please check here and explain your choice:____________

2 *

This session enhanced my professional competence or ability in the following ways: (Check all that apply)

The ability to provide compassionate, appropriate, and effective Patient Care.

Medical Knowledge.

Interpersonal and Communication Skills with patients, their families, and health professionals.

Commitment to carrying out Professional responsibilities and an adherence to ethical principles.

The ability to investigate and evaluate patient care, to appraise and assimilate scientific evidence, and to improve patient care based on self-evaluation and life-long learning.

The awareness of and the ability to call effectively on other resources in the larger context and system of health care.

None of above

Please check here and explain your choice:____________

2 Please check here and explain your choice:____________

3

My practice was/will be changed and improved in the following way(s) as a result of the content presented in the session? (Check all that apply)

Diagnostic approach

Therapeutic approach

Disease prevention or health education

System process improvement

No Change

Please check here and explain your choice:____________

3 Please check here and explain your choice:____________

4

Did/Will you use this information for specific patient(s)?

yes

No

5

If Yes, please check all that apply.

As a result of this information, I managed/will manage this patient differently.

I had several options for this patient, and I used/will use this information to justify a choice.

I thought I knew what to do, and I used/will use this information to be more certain about the management of this patient.

I used/will use this information to better understand a particular issue related to this patient.

I used/will use this information to recommend this patient, or other health professionals to make a change for this patient.

Other...

5 Other...

5

If No, please check all that apply.

This information does not apply to my patients.

This infromation is too old.

This information is too new.

This strategy is too expensive.

Patient access barriers.

System based barrier (time, staff,ect).

Other...

5 Other...

6

This patient(s) got/will get the following health benefits as a result of applying this information (Check all that apply)

This information helped/will help to improve this patient's health status, functioning or resilience (i.e., ability to adapt to significant life stressors)

This information helped/will help to prevent a disease or worsening of disease for this patient

This information helped/will help to avoid unnecessary or inappropriate treatment, diagnostic procedures, preventative interventions or a referral, for this patient

Other...

6 Other...

7

What patient/health care problem recently challenged you, and you wish you knew more about? Feedback will help formulate ideas for future Lunch and Learn topics.

8 *

This information was free of commercial bias. If no, please explain.

Yes

No, Why

8 No, Why

9 *

Comments and Feedback on the learning experience, content, procedure, and instructors, etc. in this session.

10

As a result of my participation in this activity, I am better able to... 4 - Strongly Agree 3- Agree 2 - Somewhat Disagree 1- Strongly disagree

	1	2	3	4
Identify some of the competing interests that complicate using leucovorin in autism	Identify some of the competing interests that complicate using leucovorin in autism - 1	Identify some of the competing interests that complicate using leucovorin in autism - 2	Identify some of the competing interests that complicate using leucovorin in autism - 3	Identify some of the competing interests that complicate using leucovorin in autism - 4
Articulate the current position of advocacy groups, such as the American Academy of Pediatrics (AAP) and the Society of Developmental Behavioral Pediatrics (SDBP), on using leucovorin in autism	Articulate the current position of advocacy groups, such as the American Academy of Pediatrics (AAP) and the Society of Developmental Behavioral Pediatrics (SDBP), on using leucovorin in autism - 1	Articulate the current position of advocacy groups, such as the American Academy of Pediatrics (AAP) and the Society of Developmental Behavioral Pediatrics (SDBP), on using leucovorin in autism - 2	Articulate the current position of advocacy groups, such as the American Academy of Pediatrics (AAP) and the Society of Developmental Behavioral Pediatrics (SDBP), on using leucovorin in autism - 3	Articulate the current position of advocacy groups, such as the American Academy of Pediatrics (AAP) and the Society of Developmental Behavioral Pediatrics (SDBP), on using leucovorin in autism - 4
Gain the necessary confidence, based on available information, to determine if your clinical practice will include offering leucovorin for some children with Autism	Gain the necessary confidence, based on available information, to determine if your clinical practice will include offering leucovorin for some children with Autism - 1	Gain the necessary confidence, based on available information, to determine if your clinical practice will include offering leucovorin for some children with Autism - 2	Gain the necessary confidence, based on available information, to determine if your clinical practice will include offering leucovorin for some children with Autism - 3	Gain the necessary confidence, based on available information, to determine if your clinical practice will include offering leucovorin for some children with Autism - 4
Confidently address concerns about the reported link of autism and acetaminophen	Confidently address concerns about the reported link of autism and acetaminophen - 1	Confidently address concerns about the reported link of autism and acetaminophen - 2	Confidently address concerns about the reported link of autism and acetaminophen - 3	Confidently address concerns about the reported link of autism and acetaminophen - 4

11

The following speaker(s) demonstrated experiential knowledge of the topic 4 - Strongly Agree 3- Agree 2 - Somewhat Disagree 1- Strongly Disagree

	1	2	3	4
Daniel Schulteis, MD	Daniel Schulteis, MD - 1	Daniel Schulteis, MD - 2	Daniel Schulteis, MD - 3	Daniel Schulteis, MD - 4

12

Choose the option that best fits your evaluation of this activity: 4 - Strongly Agree 3- Agree 2 - Somewhat Disagree 1- Strongly Disagree

	1	2	3	4
The content provided a fair and balanced coverage of the topic	The content provided a fair and balanced coverage of the topic - 1	The content provided a fair and balanced coverage of the topic - 2	The content provided a fair and balanced coverage of the topic - 3	The content provided a fair and balanced coverage of the topic - 4
The content was free of commercial bias	The content was free of commercial bias - 1	The content was free of commercial bias - 2	The content was free of commercial bias - 3	The content was free of commercial bias - 4

Medical College of Wisconsin

Office of Continuing and Professional Education

2025 CMG Lunch and Learn EVAL|Timely Media Topics Related to Autism

You are here

2025 CMG Lunch and Learn EVAL|Timely Media Topics Related to Autism